Advertisement
UK markets closed
  • FTSE 100

    8,213.49
    +41.34 (+0.51%)
     
  • FTSE 250

    20,164.54
    +112.21 (+0.56%)
     
  • AIM

    771.53
    +3.42 (+0.45%)
     
  • GBP/EUR

    1.1652
    -0.0031 (-0.26%)
     
  • GBP/USD

    1.2546
    +0.0013 (+0.11%)
     
  • Bitcoin GBP

    50,802.72
    +1,631.73 (+3.32%)
     
  • CMC Crypto 200

    1,359.39
    +82.41 (+6.45%)
     
  • S&P 500

    5,127.79
    +63.59 (+1.26%)
     
  • DOW

    38,675.68
    +450.02 (+1.18%)
     
  • CRUDE OIL

    77.99
    -0.96 (-1.22%)
     
  • GOLD FUTURES

    2,310.10
    +0.50 (+0.02%)
     
  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     
  • HANG SENG

    18,475.92
    +268.79 (+1.48%)
     
  • DAX

    18,001.60
    +105.10 (+0.59%)
     
  • CAC 40

    7,957.57
    +42.92 (+0.54%)
     

BW Ideol acquires 5% ownership in 30 MW EolMed floating wind pilot project (France)

BW Ideol has signed an agreement to acquire a 5% ownership in the 30MW EOLMED floating wind pilot project in the French Mediterranean. This investment confirms the company’s dual-track growth strategy as co-developer of floating wind projects and as floating foundation EPCI provider.

BW Ideol and Qair have been cooperating on the project since 2016 and the early development stages when the French government awarded the project on the merits of BW Ideol’s floating wind technology. Since, in 2020, TotalEnergies Renewables acquired a 20% ownership in the project.

EolMed is one of the first floating wind projects in the Mediterranean and is composed of three 10 MW Vestas wind turbines, currently one of the most powerful offshore wind turbines in operation in the market. The project will be installed 15 km off Gruissan, France.

“We are very pleased to further support the development of this flagship project and join EOLMED’s existing shareholders. By licensing our floater technology, providing design and engineering services and becoming a co-shareholder of the project, we are both executing our long-term growth and value creation strategy as well as strengthening our project portfolio and our unique access to a valuable return of experience”, said Paul de la Guérivière, the CEO of BW Ideol.

ADVERTISEMENT

The EolMed project is progressing towards final investment decision (FID) with an expected start of construction in early 2022.

This information is considered to be inside information pursuant to the EU Market Abuse Regulation and subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act. This stock exchange release was published by Marie Bayard-Lenoir, Communication Officer at BW Ideol, on December 1 at 8:50 CET.